NOS3 rs4884: Understanding Your Genetic Variant
The rs4884 variant is a single nucleotide polymorphism located near the NOS3 gene, which encodes the endothelial nitric oxide synthase enzyme. This variant is studied for its potential role in modulating how the body produces nitric oxide, a molecule essential for regulating blood vessel tone and exercise-related physiological responses.
What each genotype means
Typical NOS3 promoter activity
This genotype represents the common variant associated with baseline endothelial nitric oxide synthase expression. Research into this promoter-adjacent polymorphism suggests it may influence how the body regulates nitric oxide production during exercise, though the overall impact on aerobic trainability remains a subject of limited and mixed evidence. As this is a complex trait influenced by many factors, this genotype should not be used to predict specific athletic outcomes.
This is the most common genotype in many populations, particularly among those of African ancestry.
Intermediate NOS3 promoter profile
Carrying one copy of each allele may result in intermediate modulation of NOS3 transcription compared to homozygous individuals. Studies have explored whether this variation affects exercise-induced vasodilation, but current evidence is limited and results vary across different populations. This genotype is not a diagnostic marker and should be viewed as one of many factors potentially influencing physiological responses to physical training.
This heterozygous genotype is frequently observed, appearing in a significant portion of the European population.
Variant NOS3 promoter profile
This genotype involves the presence of the minor allele on both chromosomes, which has been studied for its potential role in modulating nitric oxide synthase expression. While some research suggests associations with exercise-induced vasodilation and aerobic trainability, the evidence remains limited and inconsistent across different ethnic groups. This profile does not determine fitness capacity and should not be used to guide medical or training decisions.
This genotype is less common than the others, with a frequency reflecting the minor allele prevalence of approximately 0.30 in European populations and 0.15 in African populations.
What is the rs4884 Variant?
The rs4884 variant is a specific change in the DNA sequence located in the promoter-adjacent region of the NOS3 gene. In genetics, a single nucleotide polymorphism (SNP) like rs4884 represents a variation at a single position in the genome. Because this variant sits near the regulatory regions of the NOS3 gene, researchers investigate whether it influences the transcription process—the mechanism by which the cell reads the gene to create the corresponding protein. By potentially altering the efficiency or timing of this process, rs4884 is hypothesized to affect the baseline levels of the endothelial nitric oxide synthase enzyme available in the body. While the variant itself does not change the protein structure, its location suggests a role in gene expression control, making it a subject of interest in studies regarding cardiovascular and exercise-related phenotypes.
The Role of the NOS3 Gene
The NOS3 gene provides instructions for making the enzyme endothelial nitric oxide synthase (eNOS). This enzyme is primarily found in the lining of blood vessels, known as the endothelium. Its main function is to produce nitric oxide (NO) from the amino acid L-arginine. Nitric oxide acts as a critical signaling molecule that promotes vasodilation, which is the widening of blood vessels. By relaxing the smooth muscle cells within vessel walls, nitric oxide helps maintain healthy blood pressure and ensures efficient blood flow to tissues, including skeletal muscles during physical activity. Because of its central role in vascular homeostasis, the NOS3 gene is frequently studied in the context of cardiovascular health, athletic performance, and the body's response to physical training. Proper eNOS function is essential for maintaining the delicate balance of vascular tone and supporting the cardiovascular system's ability to adapt to physiological stress.
Research Associations and Evidence Strength
Research into rs4884 and other NOS3 variants is ongoing, but the current evidence linking this specific SNP to health outcomes is considered limited. Some studies have explored whether variations in the NOS3 gene influence aerobic trainability or the body's ability to dilate blood vessels during exercise. However, findings in this field are often mixed, and it is difficult to isolate the effect of a single SNP from the complex interplay of other genetic factors, lifestyle, and environmental influences. While some literature suggests that certain NOS3 variants may be overrepresented in specific athletic populations, these associations do not imply a direct cause-and-effect relationship. It is important to recognize that genetic associations observed in research studies are statistical in nature and often require larger, more diverse cohorts to confirm. Consequently, rs4884 should not be viewed as a definitive predictor of athletic potential or cardiovascular health.
What You Can and Cannot Do With This Information
Understanding your genotype for rs4884 provides a glimpse into one small piece of your genetic makeup, but it is not a diagnostic tool. You cannot use this information to predict your future athletic performance, diagnose a cardiovascular condition, or determine your risk for specific diseases. Genetic variants like rs4884 are only one part of a much larger picture that includes your diet, exercise habits, medical history, and other genetic factors. If you are interested in how your genetics might influence your health or fitness, the most productive approach is to focus on evidence-based lifestyle choices, such as regular physical activity and a balanced diet. If you have concerns about your cardiovascular health or are considering a new, intense exercise regimen, always consult with a qualified healthcare professional or a sports medicine specialist who can provide personalized guidance based on your overall health status rather than a single genetic marker.
How common is this variant?
The minor allele frequency for rs4884 is approximately 0.30 in European populations and approximately 0.15 in African populations, indicating that the variant is relatively common but varies by ancestry.
Frequently asked questions
Can I use rs4884 to predict my athletic potential?
No. While some research explores the role of NOS3 in exercise physiology, rs4884 is not a reliable predictor of athletic ability. Performance is influenced by a vast array of genetic, environmental, and training factors.
Is rs4884 associated with heart disease?
Some studies investigate NOS3 variants in relation to cardiovascular health, but the evidence for rs4884 specifically is limited. It should not be used to assess your personal risk for heart disease.
Does my genotype mean I have a nitric oxide deficiency?
No. Your genotype for a single SNP does not determine your overall ability to produce nitric oxide. Nitric oxide production is a complex process regulated by many genes and physiological factors.
Should I change my diet based on this SNP?
There is no scientific evidence to suggest that your rs4884 genotype requires specific dietary changes. Always consult with a registered dietitian or doctor before making significant changes to your nutrition.
Sources & further reading
Educational information only, last refreshed 9/15/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4884?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in NOS3
Promoter variant (-786T>C) in the NOS3 gene associated with endothelial nitric oxide synthase expression and cardiovascular risk.
Also known as Glu298Asp (894G>T), this variant affects endothelial nitric oxide synthase cleavage and vascular tone, modulating exercise-induced vasodilation and aerobic performance.
An intronic endothelial nitric oxide synthase polymorphism that influences vascular tone, exercise-induced vasodilation, and aerobic endurance performance.
Commonly studied variant in the endothelial nitric oxide synthase gene, associated with cardiovascular traits.
Endothelial nitric oxide synthase variant implicated in blood flow response and muscle capillarization during aerobic training.
The Glu298Asp variant in the NOS3 gene is associated with altered nitric oxide production and may influence susceptibility to cardiovascular conditions like hypertension and coronary artery disease.